Global Hospital Infection Therapeutics Market 2024-2028
Technavio has been monitoring the hospital infection therapeutics market and is forecast to grow by USD 3466.6 mn during 2023-2028, accelerating at a CAGR of 5.27% during the forecast period. Our report on the hospital infection therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in incidence and prevalence of respiratory disorders, growing geriatric population, and special drug designations.
Technavio's hospital infection therapeutics market is segmented as below:
By Drug Class
- Antibiotics drugs
- Antifungal drugs
- Antiviral drugs
- Respiratory tract infections
- Surgical site infections
- Bloodstream infections
- Gastrointestinal infections
- Urinary tract infections
- North America
- Europe
- Asia
- Rest of World (ROW)
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the hospital infection therapeutics market covers the following areas:
- Hospital infection therapeutics market sizing
- Hospital infection therapeutics market forecast
- Hospital infection therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
- 1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
- 2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
- Value Chain Analysis
- 3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
- 4 Historic Market Size
- 4.1 Global Hospital Infection Therapeutics Market 2018 - 2022
- Historic Market Size - Data Table on Global Hospital Infection Therapeutics Market 2018 - 2022 ($ million)
- 4.2 Drug Class segment analysis 2018 - 2022
- Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
- 4.3 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
- 4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
- 5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
- 6 Market Segmentation by Drug Class
- 6.1 Market segments
- Chart on Drug Class - Market share 2023-2028 (%)
- Data Table on Drug Class - Market share 2023-2028 (%)
- 6.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
- 6.3 Antibiotics drugs - Market size and forecast 2023-2028
- Chart on Antibiotics drugs - Market size and forecast 2023-2028 ($ million)
- Data Table on Antibiotics drugs - Market size and forecast 2023-2028 ($ million)
- Chart on Antibiotics drugs - Year-over-year growth 2023-2028 (%)
- Data Table on Antibiotics drugs - Year-over-year growth 2023-2028 (%)
- 6.4 Antifungal drugs - Market size and forecast 2023-2028
- Chart on Antifungal drugs - Market size and forecast 2023-2028 ($ million)
- Data Table on Antifungal drugs - Market size and forecast 2023-2028 ($ million)
- Chart on Antifungal drugs - Year-over-year growth 2023-2028 (%)
- Data Table on Antifungal drugs - Year-over-year growth 2023-2028 (%)
- 6.5 Antiviral drugs - Market size and forecast 2023-2028
- Chart on Antiviral drugs - Market size and forecast 2023-2028 ($ million)
- Data Table on Antiviral drugs - Market size and forecast 2023-2028 ($ million)
- Chart on Antiviral drugs - Year-over-year growth 2023-2028 (%)
- Data Table on Antiviral drugs - Year-over-year growth 2023-2028 (%)
- 6.6 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ million)
- Data Table on Market opportunity by Drug Class ($ million)
- 7 Market Segmentation by Type
- 7.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
- 7.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 7.3 Respiratory tract infections - Market size and forecast 2023-2028
- Chart on Respiratory tract infections - Market size and forecast 2023-2028 ($ million)
- Data Table on Respiratory tract infections - Market size and forecast 2023-2028 ($ million)
- Chart on Respiratory tract infections - Year-over-year growth 2023-2028 (%)
- Data Table on Respiratory tract infections - Year-over-year growth 2023-2028 (%)
- 7.4 Surgical site infections - Market size and forecast 2023-2028
- Chart on Surgical site infections - Market size and forecast 2023-2028 ($ million)
- Data Table on Surgical site infections - Market size and forecast 2023-2028 ($ million)
- Chart on Surgical site infections - Year-over-year growth 2023-2028 (%)
- Data Table on Surgical site infections - Year-over-year growth 2023-2028 (%)
- 7.5 Bloodstream infections - Market size and forecast 2023-2028
- Chart on Bloodstream infections - Market size and forecast 2023-2028 ($ million)
- Data Table on Bloodstream infections - Market size and forecast 2023-2028 ($ million)
- Chart on Bloodstream infections - Year-over-year growth 2023-2028 (%)
- Data Table on Bloodstream infections - Year-over-year growth 2023-2028 (%)
- 7.6 Gastrointestinal infections - Market size and forecast 2023-2028
- Chart on Gastrointestinal infections - Market size and forecast 2023-2028 ($ million)
- Data Table on Gastrointestinal infections - Market size and forecast 2023-2028 ($ million)
- Chart on Gastrointestinal infections - Year-over-year growth 2023-2028 (%)
- Data Table on Gastrointestinal infections - Year-over-year growth 2023-2028 (%)
- 7.7 Urinary tract infections - Market size and forecast 2023-2028
- Chart on Urinary tract infections - Market size and forecast 2023-2028 ($ million)
- Data Table on Urinary tract infections - Market size and forecast 2023-2028 ($ million)
- Chart on Urinary tract infections - Year-over-year growth 2023-2028 (%)
- Data Table on Urinary tract infections - Year-over-year growth 2023-2028 (%)
- 7.8 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
- 8 Customer Landscape
- 8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 9 Geographic Landscape
- 9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape2023-2028 (%)
- Data Table on Market share By Geographical Landscape2023-2028 (%)
- 9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.10 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
- 9.11 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity by geography
- Market opportunity By Geographical Landscape($ million)
- Data Tables on Market opportunity By Geographical Landscape($ million)
- 10 Drivers, Challenges, and Opportunity/Restraints
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 10.4 Market opportunities/restraints
- 11 Competitive Landscape
- 11.1 Overview
- 11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 11.3 Landscape disruption
- Overview on factors of disruption
- 11.4 Industry risks
- Impact of key risks on business
- 12 Competitive Analysis
- 12.1 Companies profiled
- Companies covered
- 12.2 Market positioning of companies
- Matrix on companies position and classification
- 12.3 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- 12.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- 12.5 Achilles Therapeutics plc
- Achilles Therapeutics plc - Overview
- Achilles Therapeutics plc - Product / Service
- Achilles Therapeutics plc - Key offerings
- 12.6 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- 12.7 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- 12.8 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- 12.9 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- 12.10 Gilead Sciences Inc.
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings
- 12.11 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- 12.12 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- 12.13 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- 12.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- 12.15 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- 12.16 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- 12.17 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- 13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 13.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 13.4 Research methodology
- Research methodology
- 13.5 Data procurement
- Information sources
- 13.6 Data validation
- Data validation
- 13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 13.8 Data synthesis
- Data synthesis
- 13.9 360 degree market analysis
- 360 degree market analysis
- 13.10 List of abbreviations
- List of abbreviations
- Exhibits:
- Exhibits1: Executive Summary - Chart on Market Overview
- Exhibits2: Executive Summary - Data Table on Market Overview
- Exhibits3: Executive Summary - Chart on Global Market Characteristics
- Exhibits4: Executive Summary - Chart on Market by Geography
- Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
- Exhibits6: Executive Summary - Chart on Market Segmentation by Type
- Exhibits7: Executive Summary - Chart on Incremental Growth
- Exhibits8: Executive Summary - Data Table on Incremental Growth
- Exhibits9: Executive Summary - Chart on Company Market Positioning
- Exhibits10: Parent Market
- Exhibits11: Data Table on - Parent Market
- Exhibits12: Market characteristics analysis
- Exhibits13: Value Chain Analysis
- Exhibits14: Offerings of companies included in the market definition
- Exhibits15: Market segments
- Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits20: Historic Market Size - Data Table on Global Hospital Infection Therapeutics Market 2018 - 2022 ($ million)
- Exhibits21: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
- Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
- Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
- Exhibits25: Five forces analysis - Comparison between 2023 and 2028
- Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
- Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
- Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
- Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
- Exhibits31: Chart on Market condition - Five forces 2023 and 2028
- Exhibits32: Chart on Drug Class - Market share 2023-2028 (%)
- Exhibits33: Data Table on Drug Class - Market share 2023-2028 (%)
- Exhibits34: Chart on Comparison by Drug Class
- Exhibits35: Data Table on Comparison by Drug Class
- Exhibits36: Chart on Antibiotics drugs - Market size and forecast 2023-2028 ($ million)
- Exhibits37: Data Table on Antibiotics drugs - Market size and forecast 2023-2028 ($ million)
- Exhibits38: Chart on Antibiotics drugs - Year-over-year growth 2023-2028 (%)
- Exhibits39: Data Table on Antibiotics drugs - Year-over-year growth 2023-2028 (%)
- Exhibits40: Chart on Antifungal drugs - Market size and forecast 2023-2028 ($ million)
- Exhibits41: Data Table on Antifungal drugs - Market size and forecast 2023-2028 ($ million)
- Exhibits42: Chart on Antifungal drugs - Year-over-year growth 2023-2028 (%)
- Exhibits43: Data Table on Antifungal drugs - Year-over-year growth 2023-2028 (%)
- Exhibits44: Chart on Antiviral drugs - Market size and forecast 2023-2028 ($ million)
- Exhibits45: Data Table on Antiviral drugs - Market size and forecast 2023-2028 ($ million)
- Exhibits46: Chart on Antiviral drugs - Year-over-year growth 2023-2028 (%)
- Exhibits47: Data Table on Antiviral drugs - Year-over-year growth 2023-2028 (%)
- Exhibits48: Market opportunity by Drug Class ($ million)
- Exhibits49: Data Table on Market opportunity by Drug Class ($ million)
- Exhibits50: Chart on Type - Market share 2023-2028 (%)
- Exhibits51: Data Table on Type - Market share 2023-2028 (%)
- Exhibits52: Chart on Comparison by Type
- Exhibits53: Data Table on Comparison by Type
- Exhibits54: Chart on Respiratory tract infections - Market size and forecast 2023-2028 ($ million)
- Exhibits55: Data Table on Respiratory tract infections - Market size and forecast 2023-2028 ($ million)
- Exhibits56: Chart on Respiratory tract infections - Year-over-year growth 2023-2028 (%)
- Exhibits57: Data Table on Respiratory tract infections - Year-over-year growth 2023-2028 (%)
- Exhibits58: Chart on Surgical site infections - Market size and forecast 2023-2028 ($ million)
- Exhibits59: Data Table on Surgical site infections - Market size and forecast 2023-2028 ($ million)
- Exhibits60: Chart on Surgical site infections - Year-over-year growth 2023-2028 (%)
- Exhibits61: Data Table on Surgical site infections - Year-over-year growth 2023-2028 (%)
- Exhibits62: Chart on Bloodstream infections - Market size and forecast 2023-2028 ($ million)
- Exhibits63: Data Table on Bloodstream infections - Market size and forecast 2023-2028 ($ million)
- Exhibits64: Chart on Bloodstream infections - Year-over-year growth 2023-2028 (%)
- Exhibits65: Data Table on Bloodstream infections - Year-over-year growth 2023-2028 (%)
- Exhibits66: Chart on Gastrointestinal infections - Market size and forecast 2023-2028 ($ million)
- Exhibits67: Data Table on Gastrointestinal infections - Market size and forecast 2023-2028 ($ million)
- Exhibits68: Chart on Gastrointestinal infections - Year-over-year growth 2023-2028 (%)
- Exhibits69: Data Table on Gastrointestinal infections - Year-over-year growth 2023-2028 (%)
- Exhibits70: Chart on Urinary tract infections - Market size and forecast 2023-2028 ($ million)
- Exhibits71: Data Table on Urinary tract infections - Market size and forecast 2023-2028 ($ million)
- Exhibits72: Chart on Urinary tract infections - Year-over-year growth 2023-2028 (%)
- Exhibits73: Data Table on Urinary tract infections - Year-over-year growth 2023-2028 (%)
- Exhibits74: Market opportunity by Type ($ million)
- Exhibits75: Data Table on Market opportunity by Type ($ million)
- Exhibits76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Exhibits77: Chart on Market share By Geographical Landscape2023-2028 (%)
- Exhibits78: Data Table on Market share By Geographical Landscape2023-2028 (%)
- Exhibits79: Chart on Geographic comparison
- Exhibits80: Data Table on Geographic comparison
- Exhibits81: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibits82: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibits83: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibits84: Data Table on North America - Year-over-year growth 2023-2028 (%)
- Exhibits85: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibits86: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibits87: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits88: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits89: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibits90: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibits91: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits92: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits93: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibits94: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibits95: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits96: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits97: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibits98: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibits99: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibits100: Data Table on US - Year-over-year growth 2023-2028 (%)
- Exhibits101: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibits102: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibits103: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibits104: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%)
- Exhibits109: Chart on France - Market size and forecast 2023-2028 ($ million)
- Exhibits110: Data Table on France - Market size and forecast 2023-2028 ($ million)
- Exhibits111: Chart on France - Year-over-year growth 2023-2028 (%)
- Exhibits112: Data Table on France - Year-over-year growth 2023-2028 (%)
- Exhibits113: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibits114: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibits115: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibits116: Data Table on UK - Year-over-year growth 2023-2028 (%)
- Exhibits117: Market opportunity By Geographical Landscape($ million)
- Exhibits118: Data Tables on Market opportunity By Geographical Landscape($ million)
- Exhibits119: Impact of drivers and challenges in 2023 and 2028
- Exhibits120: Overview on criticality of inputs and factors of differentiation
- Exhibits121: Overview on factors of disruption
- Exhibits122: Impact of key risks on business
- Exhibits123: Companies covered
- Exhibits124: Matrix on companies position and classification
- Exhibits125: Abbott Laboratories - Overview
- Exhibits126: Abbott Laboratories - Business segments
- Exhibits127: Abbott Laboratories - Key news
- Exhibits128: Abbott Laboratories - Key offerings
- Exhibits129: Abbott Laboratories - Segment focus
- Exhibits130: AbbVie Inc. - Overview
- Exhibits131: AbbVie Inc. - Product / Service
- Exhibits132: AbbVie Inc. - Key news
- Exhibits133: AbbVie Inc. - Key offerings
- Exhibits134: Achilles Therapeutics plc - Overview
- Exhibits135: Achilles Therapeutics plc - Product / Service
- Exhibits136: Achilles Therapeutics plc - Key offerings
- Exhibits137: AstraZeneca Plc - Overview
- Exhibits138: AstraZeneca Plc - Product / Service
- Exhibits139: AstraZeneca Plc - Key news
- Exhibits140: AstraZeneca Plc - Key offerings
- Exhibits141: Bayer AG - Overview
- Exhibits142: Bayer AG - Business segments
- Exhibits143: Bayer AG - Key news
- Exhibits144: Bayer AG - Key offerings
- Exhibits145: Bayer AG - Segment focus
- Exhibits146: Bristol Myers Squibb Co. - Overview
- Exhibits147: Bristol Myers Squibb Co. - Product / Service
- Exhibits148: Bristol Myers Squibb Co. - Key news
- Exhibits149: Bristol Myers Squibb Co. - Key offerings
- Exhibits150: F. Hoffmann La Roche Ltd. - Overview
- Exhibits151: F. Hoffmann La Roche Ltd. - Business segments
- Exhibits152: F. Hoffmann La Roche Ltd. - Key news
- Exhibits153: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibits154: F. Hoffmann La Roche Ltd. - Segment focus
- Exhibits155: Gilead Sciences Inc. - Overview
- Exhibits156: Gilead Sciences Inc. - Product / Service
- Exhibits157: Gilead Sciences Inc. - Key news
- Exhibits158: Gilead Sciences Inc. - Key offerings
- Exhibits159: GlaxoSmithKline Plc - Overview
- Exhibits160: GlaxoSmithKline Plc - Business segments
- Exhibits161: GlaxoSmithKline Plc - Key news
- Exhibits162: GlaxoSmithKline Plc - Key offerings
- Exhibits163: GlaxoSmithKline Plc - Segment focus
- Exhibits164: Johnson and Johnson Services Inc. - Overview
- Exhibits165: Johnson and Johnson Services Inc. - Business segments
- Exhibits166: Johnson and Johnson Services Inc. - Key news
- Exhibits167: Johnson and Johnson Services Inc. - Key offerings
- Exhibits168: Johnson and Johnson Services Inc. - Segment focus
- Exhibits169: Merck and Co. Inc. - Overview
- Exhibits170: Merck and Co. Inc. - Business segments
- Exhibits171: Merck and Co. Inc. - Key news
- Exhibits172: Merck and Co. Inc. - Key offerings
- Exhibits173: Merck and Co. Inc. - Segment focus
- Exhibits174: Novartis AG - Overview
- Exhibits175: Novartis AG - Business segments
- Exhibits176: Novartis AG - Key news
- Exhibits177: Novartis AG - Key offerings
- Exhibits178: Novartis AG - Segment focus
- Exhibits179: Pfizer Inc. - Overview
- Exhibits180: Pfizer Inc. - Product / Service
- Exhibits181: Pfizer Inc. - Key news
- Exhibits182: Pfizer Inc. - Key offerings
- Exhibits183: Sanofi SA - Overview
- Exhibits184: Sanofi SA - Business segments
- Exhibits185: Sanofi SA - Key news
- Exhibits186: Sanofi SA - Key offerings
- Exhibits187: Sanofi SA - Segment focus
- Exhibits188: Viatris Inc. - Overview
- Exhibits189: Viatris Inc. - Business segments
- Exhibits190: Viatris Inc. - Key news
- Exhibits191: Viatris Inc. - Key offerings
- Exhibits192: Viatris Inc. - Segment focus
- Exhibits193: Inclusions checklist
- Exhibits194: Exclusions checklist
- Exhibits195: Currency conversion rates for US$
- Exhibits196: Research methodology
- Exhibits197: Information sources
- Exhibits198: Data validation
- Exhibits199: Validation techniques employed for market sizing
- Exhibits200: Data synthesis
- Exhibits201: 360 degree market analysis
- Exhibits202: List of abbreviations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook